Terms: = Prostate cancer AND DDX10, HRH-J8, 1662, ENSG00000178105, Q13206 AND Treatment
4 results:
1. Identification of a 9-gene signature to enhance biochemical recurrence prediction in primary prostate cancer: A benchmarking study using ten machine learning methods and twelve patient cohorts.
Yin W; Chen G; Li Y; Li R; Jia Z; Zhong C; Wang S; Mao X; Cai Z; Deng J; Zhong W; Pan B; Lu J
Cancer Lett; 2024 Apr; 588():216739. PubMed ID: 38395379
[TBL] [Abstract] [Full Text] [Related]
2. CYP27A1 Loss Dysregulates Cholesterol Homeostasis in prostate cancer.
Alfaqih MA; Nelson ER; Liu W; Safi R; Jasper JS; Macias E; Geradts J; Thompson JW; Dubois LG; Freeman MR; Chang CY; Chi JT; McDonnell DP; Freedland SJ
Cancer Res; 2017 Apr; 77(7):1662-1673. PubMed ID: 28130224
[TBL] [Abstract] [Full Text] [Related]
3. [The general practitioner's part in the initiation of diagnostic procedures in prostate cancer].
Braun KP; May M; Grassmel Y; Führer S; Hoschke B; Braun V
Aktuelle Urol; 2008 Mar; 39(2):141-6. PubMed ID: 18379968
[TBL] [Abstract] [Full Text] [Related]
4. Outcome profiles of locoregional disease after radical prostatectomy and radiotherapy.
Dahm P; Vieweg J; Newhall PM; Robertson JE; Paulson DF
World J Urol; 2000 Jun; 18(3):173-8. PubMed ID: 10926080
[TBL] [Abstract] [Full Text] [Related]
